Adage Capital Partners
BMY.RT

Adage Capital Partners’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Adage Capital Partners’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,725,497
Closed -$9.47M – 1102
2020
Q4 		$9.47M Sell
13,725,497
-1,074,503
-7% -$2.29M 0.02% 604
2020
Q3 		$33.3M Buy
14,800,000
+1,084,159
+8% +$3.1M 0.08% 254
2020
Q2 		$49.1M Buy
13,715,841
+550,000
+4% +$1.98M 0.13% 186
2020
Q1 		$50M Sell
13,165,841
-5,221,199
-28% -$17.2M 0.15% 168
2019
Q4 		$55.3M Buy
+18,387,040
New +$47.8M 0.14% 189

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $27.4M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return